| 93955-3 |
Consultation note |
Find |
{Setting} |
Pt |
Doc |
Wound, ostomy, and continence care |
|
ACTIVE |
Wound, Ostomy, and Continence Care Consult note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93955-3 |
|
Wound, ostomy, and continence care |
|
|
Both |
|
|
|
0 |
WOC Consult note |
|
|
|
|
|
Consult note; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note; WOC |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93956-1 |
Letter |
Find |
{Setting} |
Pt |
Doc |
Heart failure+Transplant cardiology |
|
ACTIVE |
Heart failure+Transplant cardiology Letter |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93956-1 |
|
Heart failure+Transplant cardiology |
|
|
Both |
|
|
|
0 |
HF+TC Letter |
|
|
|
|
|
DOC.ONT; Document; Finding; Findings; Heart function; HF+TC; Point in time; Random; TC |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93957-9 |
Diagnostic study note |
Find |
{Setting} |
Pt |
Doc |
Developmental-behavioral pediatrics |
|
ACTIVE |
Developmental-behavioral pediatrics Diagnostic study note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93957-9 |
|
Developmental-behavioral pediatrics |
|
|
Both |
|
|
|
0 |
Develop-behav peds Diag study note |
|
|
|
|
|
Develop-behav peds; Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Peds; Point in time; Random; Study report; Visit note |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93958-7 |
Diagnostic study note |
Find |
{Setting} |
Pt |
Doc |
Eating disorders |
|
ACTIVE |
Eating disorders Diagnostic study note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93958-7 |
|
Eating disorders |
|
|
Both |
|
|
|
0 |
Eating disorders Diag study note |
|
|
|
|
|
Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93959-5 |
Diagnostic study note |
Find |
{Setting} |
Pt |
Doc |
Heart failure+Transplant cardiology |
|
ACTIVE |
Heart failure+Transplant cardiology Diagnostic study note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93959-5 |
|
Heart failure+Transplant cardiology |
|
|
Both |
|
|
|
0 |
HF+TC Diag study note |
|
|
|
|
|
Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart function; HF+TC; notes; Point in time; Random; Study report; TC; Visit note |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 9396-3 |
SUFentanil |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
SUFentanil [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
9396-3 |
|
|
|
|
Both |
|
|
|
0 |
SUFentanil Ur-mCnc |
|
|
|
Y |
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sufenta; UA; UR; Urn |
2.73 |
1.0i |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 93960-3 |
Diagnostic study note |
Find |
{Setting} |
Pt |
Doc |
Immunology |
|
ACTIVE |
Immunology Diagnostic study note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93960-3 |
|
Immunology |
|
|
Both |
|
|
|
0 |
Immunology Diag study note |
|
|
|
|
|
Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93961-1 |
Diagnostic study note |
Find |
{Setting} |
Pt |
Doc |
Integrative medicine |
|
ACTIVE |
Integrative medicine Diagnostic study note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93961-1 |
|
Integrative medicine |
|
|
Both |
|
|
|
0 |
Integrative medicine Diag study note |
|
|
|
|
|
Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Integrated medicine; notes; Point in time; Random; Study report; Visit note |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93962-9 |
Diagnostic study note |
Find |
{Setting} |
Pt |
Doc |
Nephrology |
|
ACTIVE |
Nephrology Diagnostic study note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93962-9 |
|
Nephrology |
|
|
Both |
|
|
|
0 |
Nephrology Diag study note |
|
|
|
|
|
Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93963-7 |
Diagnostic study note |
Find |
{Setting} |
Pt |
Doc |
Pediatrics |
|
ACTIVE |
Pediatrics Diagnostic study note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93963-7 |
|
Pediatrics |
|
|
Both |
|
|
|
0 |
Peds Diag study note |
|
|
|
|
|
Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Peds; Point in time; Random; Study report; Visit note |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93964-5 |
Diagnostic study note |
Find |
{Setting} |
Pt |
Doc |
Pharmacogenomics |
|
ACTIVE |
Pharmacogenomics Diagnostic study note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93964-5 |
|
Pharmacogenomics |
|
|
Both |
|
|
|
0 |
Pharmacogenomics Diag study note |
|
|
|
|
|
Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93965-2 |
Diagnostic study note |
Find |
{Setting} |
Pt |
Doc |
Physical medicine and rehab |
|
ACTIVE |
Physical medicine and rehab Diagnostic study note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93965-2 |
|
Physical medicine and rehab |
|
|
Both |
|
|
|
0 |
PM+R Diag study note |
|
|
|
|
|
Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; PM+R; Point in time; Random; Study report; Visit note |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93966-0 |
Diagnostic study note |
Find |
{Setting} |
Pt |
Doc |
Plastic surgery |
|
ACTIVE |
Plastic surgery Diagnostic study note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93966-0 |
|
Plastic surgery |
|
|
Both |
|
|
|
0 |
Plastic surgery Diag study note |
|
|
|
|
|
Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Surg; Visit note |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93967-8 |
Diagnostic study note |
Find |
{Setting} |
Pt |
Doc |
Psychiatry |
|
ACTIVE |
Psychiatry Diagnostic study note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93967-8 |
|
Psychiatry |
|
|
Both |
|
|
|
0 |
Psychiatric Diag study note |
|
|
|
|
|
Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Psychiatric; Random; Study report; Visit note |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93968-6 |
Diagnostic study note |
Find |
{Setting} |
Pt |
Doc |
Psychology |
|
ACTIVE |
Psychology Diagnostic study note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93968-6 |
|
Psychology |
|
|
Both |
|
|
|
0 |
Psych Diag study note |
|
|
|
|
|
Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93969-4 |
Diagnostic study note |
Find |
{Setting} |
Pt |
Doc |
Trauma |
|
ACTIVE |
Trauma Diagnostic study note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93969-4 |
|
Trauma |
|
|
Both |
|
|
|
0 |
Trauma Diag study note |
|
|
|
|
|
Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 9397-1 |
Observation |
Color |
Stool |
Pt |
Nom |
|
|
ACTIVE |
Color of Stool |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SPEC |
|
9397-1 |
|
|
|
|
Observation |
|
|
|
0 |
Color Stl |
|
|
|
|
|
Bowel movement; Faecal; Faeces; Fecal; Feces; Nominal; Point in time; Random; SPEC; Stl; Stool = Fecal |
2.79 |
1.0i |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by coll w SCT: component that the description is property like as in Color, Appearance, Osmolality have changed to Component: Observation, and Property: Color, or Appearance, or Osmolality, so forth�; |
0 |
| 93970-2 |
Diagnostic study note |
Find |
{Setting} |
Pt |
Doc |
Wound, ostomy, and continence care |
|
ACTIVE |
Wound, Ostomy, and Continence Care Diagnostic study note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93970-2 |
|
Wound, ostomy, and continence care |
|
|
Both |
|
|
|
0 |
WOC Diag study note |
|
|
|
|
|
Continuity assessment record and evaluation; Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note; WOC |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93971-0 |
Elevation climbed |
LRat |
^Patient |
24H |
Qn |
|
|
ACTIVE |
Elevation climbed [Length/Time] 24 hour |
|
ADD |
DefinitionDescription |
|
|
ft/24H |
|
|
|
|
|
|
H&P.HX |
|
93971-0 |
|
|
|
|
Both |
|
|
|
0 |
Elevation climbed 24h lRate |
|
|
|
|
|
1 day; 24 hours; 24HR; Elevation gain; Elevation gained; H+P; H+P.HX; lRate; P prime; QNT; Quan; Quant; Quantitative |
2.67 |
2.67 |
|
|
|
|
|
|
|
[ft_i]/(24.h) |
|
|
|
0 |
| 93972-8 |
Acetaminophen-cysteine adduct |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Acetaminophen-cysteine adduct [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/mL |
|
|
|
|
|
|
DRUG/TOX |
|
93972-8 |
|
|
|
|
Both |
|
|
|
0 |
APAP-Cysteine SerPl-sCnc |
|
|
|
|
|
3-(cystein-S-yl)-acetaminophen; ACET; Acetamidophenol; Acetaminoph; Acetaminophen-cysteine conjugate; Acetominophen; APAP; APAP-CYS; APAP-Cysteine; c209; C55; Cys; DRUG/TOXICOLOGY; Drugs; Hepatotoxicity; Hydroxyacetanilide; Level; N-(4-Hydroxyphenyl)acetanilide; N-Acetyl-p-aminophenol; N-acetyl-p-benzoquinone imine (NAPQI); p-Acetamidophenol; Paracetamol; p-Hydroxyacetanilide; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tylenol; u209 |
2.72 |
2.67 |
|
|
|
|
|
|
|
nmol/mL |
|
|
|
0 |
| 93973-6 |
Iohexol |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Iohexol [Mass/volume] in Urine |
|
ADD |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
CHEM |
|
93973-6 |
|
|
|
|
Both |
|
|
|
0 |
Iohexol Ur-mCnc |
|
|
|
|
|
Chemistry; Level; Mass concentration; Omnipaque; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.67 |
2.67 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 93974-4 |
Iohexol |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Iohexol [Mass/volume] in Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
CHEM |
|
93974-4 |
|
|
|
|
Both |
|
|
|
0 |
Iohexol SerPl-mCnc |
|
|
|
|
|
Chemistry; Level; Mass concentration; Omnipaque; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.67 |
2.67 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 93975-1 |
Urea nitrogen^1H specimen |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Urea nitrogen [Mass/volume] in Serum or Plasma --1 hour specimen |
|
ADD |
DefinitionDescription |
|
|
mg/dl |
|
|
|
|
|
|
CHEM |
|
93975-1 |
|
|
|
|
Observation |
|
|
|
0 |
BUN 1h spec SerPl-mCnc |
|
|
|
|
|
1 hour; 1.0Hr; 60 min; 60 minutes; 60M; 60min; Blood urea nitrogen; BUN; Chemistry; Level; Mass concentration; N; N2; Nit; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR; UN |
2.67 |
2.67 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 93976-9 |
Chikungunya virus Ab.IgM & IgG panel |
- |
Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Chikungunya virus Ab.IgM and IgG panel - Serum or Plasma |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
93976-9 |
|
|
|
|
Order |
|
|
|
0 |
CHIKV IgG+IgM Pnl SerPl |
|
|
|
|
|
CHIKV; CHIKV IgG+IgM Pnl; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.72 |
2.67 |
|
Panel |
|
|
|
|
|
|
|
|
Release 2.72: SYSTEM: Updated to Ser/Plas for consistency of usage. Removed scale from panel to allow inclusion of quantitative terms.; |
0 |
| 93977-7 |
Complement C2.functional |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Complement C2.functional [Units/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
HEM/BC |
|
93977-7 |
|
|
|
|
Both |
|
|
|
0 |
C2.functional SerPl-aCnc |
|
|
|
|
|
Arbitrary concentration; Comp; Complmt; HEMATOLOGY/CELL COUNTS; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.68 |
2.67 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
